CTOs on the Move

Renue Physical Therapy

www.renuept.com

 
Renue Physical Therapy was established in the Fall of 2011 with one clinic on Bay Road in Saginaw. Our goal from the start was to create a fully patient-focused practice model. We take pride in offering one-on-one treatment with the same therapy team throughout the course of therapy, providing a customized plan that is specific to your needs to help you achieve the best possible outcomes. Since our start in 2011, Renue has grown to more than 12 clinics serving the Great Lakes Bay Region and beyond, with locations in Auburn, Au Gres, Bay City, Bridgeport, Caro, Freeland, Midland, Saginaw ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.renuept.com
  • 804 North Water Street
    Bay City, MI USA 48708
  • Phone: 989.450.3341

Executives

Name Title Contact Details
Bob Klapish
 Chief Operating Officer Profile

Similar Companies

Essen Health Care

essen Health Care is a healthcare continuum in New York with over 300 providers across Manhattan, Bronx, Queens, Staten Island, Long Island and Westchester County. Essen is a patient focused integrated healthcare delivery platform with the goal of prov...

Toby Orthopaedics

Toby Orthopaedics is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.

BioMedica Diagnostics

BioMedica Diagnostics Inc. is a Windsor, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rexton

Rexton is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.